期刊
CLINICS IN PLASTIC SURGERY
卷 42, 期 4, 页码 605-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.cps.2015.06.006
关键词
Breast implant-associated ALCL; Anaplastic large cell lymphoma; Non-Hodgkin lymphoma; CD30
类别
资金
- Cancer Center Support Grant (NCI Grant) [P30 CA016672]
Breast implant associated anaplastic large cell lymphoma (BIALCL) is a distinct clinical entity that can present in patients receiving either reconstructive or cosmetic breast implants. Presenting symptoms include onset of a delayed (>1 year after implantation) fluid collection, mass of the capsule, or lymphadenopathy. Treatment has progressed in recent years and most commonly includes implant removal and total resection of the tumor, including capsule, mass, and involved lymph nodes. Further research is warranted to determine potential malignant drivers, disease progression, and optimal treatment strategies in advanced disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据